Purchase Order 15DDHQ26P00000194
- Not listed
- The U.S. Drug Enforcement Administration (DEA) awarded a $80,800.00 firm fixed price purchase order to Cayman Chemical Co Inc., a leading supplier of biochemical products and research tools to federal agencies. The purchase order is for the delivery of 16 synthetic substances, which Cayman Chemical specializes in producing. Cayman Chemical has established long-term relationships with government agencies, including the DEA, Centers for Disease Control and Prevention (CDC), Department of the Army,...
- This is a $27,350.00 firm fixed price purchase order awarded to Cayman Chemical Co Inc. by the Drug Enforcement Administration (DEA) on August 1, 2024. The contract is for the purchase of three substances to be used in testing, with a delivery date of December 20, 2024. Cayman Chemical Co Inc. is a leading supplier of biochemical products and research tools to federal agencies, specializing in the production of high-quality chemicals, assay kits, antibodies, and recombinant proteins. The company...
- This is a firm fixed-price purchase order awarded by the Drug Enforcement Administration (DEA) to Cayman Chemical Co Inc. for $84,575.00. The contract is for the purchase of 17 substances for diversion and control purposes. Cayman Chemical Co Inc. is a leading supplier of biochemical products and research tools to federal agencies, specializing in the production of high-quality chemicals, assay kits, antibodies, and recombinant proteins. The contract has a total small business set-aside...
- This is a $38,450.00 firm fixed price purchase order awarded by the Drug Enforcement Administration (DEA) to Cayman Chemical Co Inc., a for-profit manufacturer of biochemical products and research tools. The purchase order is for 8 substances and has a completion date of June 27, 2024. Cayman Chemical is a major supplier of reference materials, analytical standards, and specialized reagents to federal agencies for drug enforcement, public health, and biomedical research. The company has...
- This is a $19,153.30 firm fixed-price purchase order awarded to Cayman Chemical Co Inc., a manufacturer of biochemicals, assay kits, and other chemical products. The order is for the Drug Enforcement Administration and has a delivery date of April 30, 2024. Cayman Chemical has provided similar products and services to federal agencies like the CDC and Department of Defense in support of drug enforcement operations, forensic analysis, and substance abuse prevention efforts. The company has...
- The Department of Justice Drug Enforcement Administration awarded a $21,655 purchase order to Cayman Chemical Co Inc. to provide reference materials for use in evidence analysis, method development, and method verification. The contract has a period of performance from August 2, 2023 through August 1, 2024 and utilizes a firm fixed price arrangement. Cayman Chemical will deliver the reference materials to sites in Sterling, Virginia to support the DEA's efforts in forensic analysis and...
- The Department of Justice Drug Enforcement Administration awarded a $22,850 purchase order to Cayman Chemical Co Inc. to provide reference materials needed to fulfill laboratory system requests for evidence analysis in support of DOJ programs. The one-year contract running from June 30, 2023 to June 29, 2024 utilizes a firm fixed price arrangement for the reference materials, which will be delivered to and utilized at the prime contractor's facility in Sterling, Virginia. No set aside...
- This is a contract awarded by the NIAID DEA OA Acquisitions division of the Department of Health and Human Services (HHS) to Cayman Chemical Co Inc., a for-profit manufacturer of biochemical products and research tools. The contract is for the purchase of a PRECELLYS MINILYS-PERSONAL TISSUE HOMOGEIZER, catalog# 10435, with a ceiling value of $3,781.00. It is a firm fixed price purchase order with a completion date of February 18, 2012. The contract does not have a set-aside designation. Cayman...
- Cayman Chemical Co Inc. was awarded a $4,023,437.50 firm fixed price delivery order against an unspecified multiple award contract vehicle by the Centers for Disease Control and Prevention (CDC). The delivery order is for the provision of traceable opioid kits, known as FAS kits, to the CDC. Performance will take place in Ann Arbor, Michigan with all work required to be completed by September 29, 2020. No subcontractors or set-aside designations were identified. The CDC works to protect public...
- The Drug Enforcement Administration (DEA) awarded a $71,474.90 firm-fixed-price purchase order to VHG Labs Inc. on September 8, 2025, for the synthesis and supply of chemical research substances. The contract, issued under Request for Quotation 15DDHQ25Q00000128, covers 19 different controlled substances and synthetic drugs in specified quantities (1g or 500mg amounts), including Metizolam, Deschloroetizolam, various pyrrolidinophenones, synthetic cannabinoids such as delta9-THCB and...
Cayman Chemical Co Inc., a specialized biochemical manufacturer based in Ann Arbor, Michigan, has been awarded a $230,365 firm fixed-price purchase order by the Drug Enforcement Administration (DEA) for the synthesis of drug substances. The contract, awarded on January 22, 2026, with an ultimate completion date of August 31, 2026, follows the company's response to a DEA Aviation Division Sources Sought notice issued in late December 2025. The opportunity sought vendors capable of providing synthetic substances for diversion control and pharmacological activity testing purposes. No set-aside designation applies to this award, and performance will be conducted at the contractor's Ann Arbor facility. Cayman Chemical Co Inc. is well-positioned to fulfill this requirement given its extensive experience supplying specialized chemical substances and reference materials to federal agencies since 2005, with the DEA representing its most frequent contracting partner. The company currently holds two significant Indefinite Delivery Vehicles, including a $1.5 million Blanket Purchase Agreement with the Defense Health Agency for synthetic cannabinoids and novel psychoactive substances, and a $130,000 agreement with the Department of the Army Medical Command for forensic drug testing chemicals. This purchase order represents another demonstration of the DEA's reliance on Cayman Chemical's technical capabilities for drug enforcement and diversion control operations.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Synthetic Substances for Diversion and Control Purposes | D-26-DO-0004 | Department of Justice Drug Enforcement Administration | Solicitation 2/2 | 1/12/26, 9:09 AM | |
Synthetic Substances for Diversion and Control Purposes | D-26-DO-0004 | Department of Justice Drug Enforcement Administration | Pre-Solicitation 1/2 | 12/29/25, 3:33 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $230.4k | 1/22/26 |